Narcotic Use and Postoperative Doctor Shopping in the Orthopaedic Trauma Population

2014 ◽  
Vol 96 (15) ◽  
pp. 1257-1262 ◽  
Author(s):  
Brent J. Morris ◽  
Justin W. Zumsteg ◽  
Kristin R. Archer ◽  
Brian Cash ◽  
Hassan R. Mir
2020 ◽  
Vol 34 (5) ◽  
pp. e165-e169
Author(s):  
Alexander S. Rascoe ◽  
Michael D. Kavanagh ◽  
Mary A. Breslin ◽  
Emily Hu ◽  
Heather A. Vallier

2013 ◽  
Vol 27 (10) ◽  
pp. 558-562 ◽  
Author(s):  
Robert Petretta ◽  
Mark McConkey ◽  
Gerard P. Slobogean ◽  
James Handel ◽  
Henry M. Broekhuyse

Injury ◽  
2015 ◽  
Vol 46 (4) ◽  
pp. 542-546 ◽  
Author(s):  
Rivka C. Ihejirika ◽  
Rachel V. Thakore ◽  
Vasanth Sathiyakumar ◽  
Jesse M. Ehrenfeld ◽  
William T. Obremskey ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Dana Alkhoury ◽  
Jared Atchison ◽  
Antonio J. Trujillo ◽  
Kimberly Oslin ◽  
Katherine P. Frey ◽  
...  

Abstract Background Smoking increases the risk of complications and related costs after an orthopaedic fracture. Research in other populations suggests that a one-time payment may incentivize smoking cessation. However, little is known on fracture patients’ willingness to accept financial incentives to stop smoking; and the level of incentive required to motivate smoking cessation in this population. This study aimed to estimate the financial threshold required to motivate fracture patients to stop smoking after injury. Methods This cross-sectional study utilized a discrete choice experiment (DCE) to elicit patient preferences towards financial incentives and reduced complications associated with smoking cessation. We presented participants with 12 hypothetical options with several attributes with varying levels. The respondents’ data was used to determine the utility of each attribute level and the relative importance associated with each attribute. Results Of the 130 enrolled patients, 79% reported an interest in quitting smoking. We estimated the financial incentive to be of greater relative importance (ri) (45%) than any of the included clinical benefits of smoking cessations (deep infection (ri: 24%), bone healing complications (ri: 19%), and superficial infections (ri: 12%)). A one-time payment of $800 provided the greatest utility to the respondents (0.64, 95% CI: 0.36 to 0.93), surpassing the utility associated with a single $1000 financial incentive (0.36, 95% CI: 0.18 to 0.55). Conclusions Financial incentives may be an effective tool to promote smoking cessation in the orthopaedic trauma population. The findings of this study define optimal payment thresholds for smoking cessation programs.


2014 ◽  
Vol 28 (4) ◽  
pp. e80-e84 ◽  
Author(s):  
Brent J. Morris ◽  
Justin E. Richards ◽  
Kristin R. Archer ◽  
Melissa Lasater ◽  
Denise Rabalais ◽  
...  

2017 ◽  
Vol 31 (6) ◽  
pp. e190-e194 ◽  
Author(s):  
Anup K. Gangavalli ◽  
Ajith Malige ◽  
Saqib Rehman ◽  
Chinenye O. Nwachuku

BMJ Open ◽  
2020 ◽  
Vol 10 (3) ◽  
pp. e033453
Author(s):  
Mélanie Bérubé ◽  
Lynne Moore ◽  
Stéphane Leduc ◽  
Imen Farhat ◽  
Martin Lesieur ◽  
...  

IntroductionOrthopaedic injuries affect almost 90% of trauma patients. A previous scoping review and expert consultation survey identified 15 potential low-value intra-hospital practices in the adult orthopaedic trauma population. Limiting the frequency of such practices could reduce adverse events, improve clinical outcomes and free up resources. The aim of this study is to synthesise the evidence on intra-hospital practices for orthopaedic injuries, previously identified as potentially of low value.Methods and analysisWe will search Medline, Excerpta Medica Database (EMBASE), the Cochrane Central Register of Controlled Trials and Epistemonikos to identify systematic reviews, randomised controlled trials (RCTs), quasi-RCTs, cohort studies and case–control studies that evaluate selected practices according to a priori PICOS statements (Population–Intervention–Comparator–Outcome–Study design) . We will evaluate the methodological quality for systematic reviews using the Measurement Tool to Assess Systematic Reviews version 2 (AMSTAR-2). Risk of bias in original studies will be evaluated with the Cochrane revised tool for RCTs (RoB2) and with the risk of bias in non-randomised studies of interventions (ROBINS-I) tool. If for a given practice, more than two original studies on our primary outcome are identified, we will conduct meta-analysis using a random effects model and assess heterogeneity using the I2index. We will assess credibility of evidence (I–IV) based on statistical significance, sample size, heterogeneity and bias as per published criteria.Ethics and disseminationEthics approval is not required as original data will not be collected. Knowledge users from three level I trauma centres are involved in the design and conduct of the study in accordance with an integrated knowledge translation approach. Findings related to the rapid review will be available in May 2020. They will be presented to key stakeholders to inform discussions and raise awareness on low-value injury care. In addition, results will be disseminated in a peer-reviewed journal, at national and international scientific meetings and to healthcare associations.


2019 ◽  
Vol 27 (10) ◽  
pp. e473-e481 ◽  
Author(s):  
Cody L. Evans ◽  
David M. Kahler ◽  
David B. Weiss ◽  
Seth R. Yarboro

2018 ◽  
Vol 32 (4) ◽  
pp. e129-e133 ◽  
Author(s):  
Brendan A. Andres ◽  
Benjamin R. Childs ◽  
Heather A. Vallier

2017 ◽  
Vol 31 (6) ◽  
pp. e179-e185 ◽  
Author(s):  
John Ruder ◽  
Meghan K. Wally ◽  
McKell Oliverio ◽  
Rachel B. Seymour ◽  
Joseph R. Hsu

Sign in / Sign up

Export Citation Format

Share Document